Executive Q & A: Dr. Patricio Frias, Rady Children’s Hospital

Dr. Patricio “Patrick” A. Frias’ is a physician-turned-executive, a path that helped land a new gig as the president and CEO of Rady Children’s Hospital and Health Center.

Tease photo

Inscripta Acquires Solana Biosciences

Inscripta has purchased Solana Biosciences, a San Diego company led by former Illumina veterans that specializes in genomics manufacturing operations.

ResMed Files Patent Infringement Petition Against Fisher & Paykel

San Diego-based ResMed has filed a patent infringement petition that is seeking to ban the U.S. import and sale of select breathing masks from New Zealand-based Fisher & Paykel.

IPO Puts Crinetics In Position to Compete

BIOTECH: Oral Drug Replaces Shot, Aims for Greater Efficacy

After early years operating on a shoestring budget, Crinetics Pharmaceuticals is flush with cash to pursue ambitious drug development plans.

Tease photo

Ionis Feels Effect of FDA’s Ruling

The U.S. Food and Drug Administration on Aug. 26 declined to approve Waylivra, a drug from Ionis Pharmaceuticals targeting an ultra-rare disease.

Clinical Research Organization Prosciento Names New COO

Dr. Linda Morrow, COO since 2009, becomes Prosciento's chief medical officer.

Illumina System Gains Approval in China

Illumina notched approval from the China National Drug Administration to market and sell its MiSeqDx sequencing system to hospitals and other medical institutions throughout the country.

Althea Expands Into New Manufacturing Space

Ajinomoto Althea Inc., the biopharmaceutical contract development and manufacturing company, has opened a 57,000-square-foot manufacturing facility in Sorrento Mesa.

Biotechs Find Favorable Conditions in UTC As An Amenity-Rich Alternative to Torrey Pines

When scouting where to consolidate San Diego operations, Takeda Pharmaceuticals put together a checklist. Most pressing: a plot that could accommodate 300 employees, near research institutions and other life science companies.

Tease photo

Ionis Pharmaceuticals’ Stock Drops After FDA Letter

Shares of Ionis Pharmaceuticals and spinout Akcea Therapeutics kept falling Tuesday morning after a U.S. Food and Drug Administration division failed to sign off on their drug Waylivra.

J. Craig Venter Institute Calls for Dismissal of Lawsuit

The J. Craig Venter Institute filed a motion to dismiss a lawsuit alleging that its CEO, J. Craig Venter, took trade secrets from former employer Human Longevity.

Rakuten Aspyrian Raises $150 Million in Series C Round

Rakuten Aspyrian hauled in a $150 million Series C round as the company’s lead cancer candidate moves into a final-stage trial.

Viterbi Gives $50M to UC San Diego

Businessman, academic and philanthropist Andrew J. Viterbi has given $50 million to UC San Diego to support its ophthalmology programs.

Dthera Sciences Nabs FDA Breakthrough Designation

Dthera Sciences’ device intended for Alzheimer’s patients has received a breakthrough designation that will speed regulatory review.

Kane Named CEO of UC San Diego Health Physicians

Dr. Christopher Kane will lead the charge to expand primary care access, among other goals, in new roles as dean of clinical affairs for UC San Diego School of Medicine and CEO of UC San Diego Health Physicians.